4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-132885
Chief Medical Officer sold 5,421 shares at $5.54 ($30,007)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bedrosian Camille L Chief Medical Officer | 2024-12-02 | Sale | −5,421 | $5.54 | $30,007 | 138,380 | D |
| Open-market sales · 5,421 sh · avg $5.54 · $30,007 | |||||||
Loading xslF345X05/ownership.xml…